开盘$144.34
昨收$146.94
当日区间$142.80 – $147.48
成交量7.63M
市值$361.73B
市盈率（TTM）148.2
股息率2.32%
MRK 相关新闻
匹配 Merck & Co 或代码 MRK 的头条新闻，按最新排序。
- Wells Fargo Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $170 正面
- RBC Capital Maintains Merck & Co(MRK.US) With Hold Rating, Maintains Target Price $150
- BofA Securities Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $166
- Scotiabank Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $155
- OKX announced the listing of five tokens, including MRK perpetual contracts, WMT perpetual contracts, and MARA perpetual contracts.
- Argus Research Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $170 正面
- Wolfe Research Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $180 正面
- Leerink Partners Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $161 正面
- Barclays Downgrades Merck & Co(MRK.US) to Hold Rating, Raises Target Price to $174.46 中性
- Guggenheim Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $170 正面
- Scotiabank Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $180 正面
- BMO Capital Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $170
- Analysts Offer Insights on Healthcare Companies: Prime Medicine, Inc. (PRME) and Merck & Company (MRK)
- UBS Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $175
- BofA Securities Maintains Merck & Co(MRK.US) With Buy Rating, Maintains Target Price $166
暂无评论——快来第一个聊聊 MRK。
登录后参与讨论。